Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
מצבים רפואיים
Oligometastatic Disease · Oligoprogression · Toxicity Due to Radiotherapy · Quality of Life
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
BC Cancer, Kelowna, British Columbia, Canada
BC Cancer, Prince George, British Columbia, Canada
Contact: Principal Investigator (Robert A Olson)BC Cancer, Surrey, British Columbia, Canada
BC Cancer, Vancouver, British Columbia, Canada
BC Cancer - Victoria, Victoria, British Columbia, Canada
Health Sciences North Research Institute, Greater Sudbury, Ontario, Canada
Contact: Principal Investigator (Andrew Pearce)Princess Margaret Cancer Centre | University Health Network, Toronto, Ontario, Canada
Contact: Principal Investigator (Chiaojung Jillian Tsai)University Hospital Galway, Galway, Connacht, Ireland
Contact: Principal Investigator (Ronan McDermott)St. Luke's Radiation Oncology Network, Dublin, Dublin, Ireland
Contact: Principal Investigator (Lorna Keenan)Mater Private Hospital, Dublin, Leinster, Ireland
Contact: Principal Investigator (Daniel Cagney)Beacon Hospital, Dublin, Leinster, Ireland
Contact: Principal Investigator (Alina Mihai)Cork University Hospital, Cork, Munster, Ireland
Contact: Principal Investigator (Aisling Barry)Bon Secours Radiotherapy Cork in Partnership with UPMC Hillman Cancer Centre, Cork, Munster, Ireland
Contact: Principal Investigator (Paul Kelly)UPMC Whitfield Hospital - Waterford, Waterford, Munster, Ireland
Contact: Principal Investigator (Ciara Lyons)
מובילי המחקר
Robert Olson, MD, MSc, FRCPC
Principal Investigator
BC Cancer - Prince George